Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE.
Kerry A CaseyXiang GuoMichael A SmithShiliang WangDominic SinibaldiMiguel A SanjuanLiangwei WangGabor G IlleiWendy I WhitePublished in: Lupus science & medicine (2018)
NCT01438489.